WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

FORMULATION AND EVALUATION OF TRANSDERMAL PATCHES: A SHORT REVIEW

*Ramesh Kundlik Aghav, Nikhil Sopan Katore, Siddheshwar Rohidas Kudke, Ashok Baban Shimple and Rohan J. Jadhav

ABSTRACT

Since the start of life on the earth, humans have applied plenty of substances to their skin as cosmetics and therapeutic agents. However, it was the 20th century once the skin became used as route for future drug delivery. Today about two third of drugs (available in market) are taken orally, but these aren’t as effective as required. To enhance upon the features the transdermal drug delivery system was emerged. Amongst all techniques that transdermal drug delivery systems (TDDS), also referred to as “patches,” are dosage forms designed to deliver therapeutically effective quantity of drug across a patient’s Skin. It give controlled continuous delivery of drugs via the skin to the systemic circulation. Advantage of transdermal drug delivery system are limitation of hepatic first pass metabolism, improvement of therapeutic potency and maintenance of steady plasma level of thedrug. transdermal patch (Skin Patch) uses a special membrane to control the rate at which the liquid drug contained in the reservoir within the patch will pass through the skin and into the bloodstream. Drugs administered through skin patches include scopolamine (for motion sickness), nicotine (for quitting smoking), estrogen (for menopause and to stop osteoporosis after menopause), nitroglycerin (for angina), and lidocaine to relieve the pain of shingles (herpes zoster). Transdermal patches were developed in the 1970s and the first was approved by the FDA in 1979 for the treatment of motion Sickness. in 1981, patches for nitroglycerin were approved, and today there exist variety of patches for drugs such as clonidine, fentanyl, Lidocaine, nicotine, nitroglycerin, estradiol, Oxybutinin, scopolamine, and testosterone. There are combination patches for Contraception, also as hormone replacement. Depending on the drug, the patches typically last from 1 to 7 days. Some drugs should be combined with substances, such as alcohol, that increase their ability to penetrate the skin so as to be used in skin.

Keywords: Transdermal drug delivery systems (TDDS), Diffusion, Sustained drug delivery, First-generation TDS, Second-generation TDS, Polymer Matrix, Permeation enhancers, Iontophoresis, Microneedles.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More